ArticleViolence against women2026
Introducing a Chatbot to Support Victim-Survivors of Domestic Abuse: Victim-Survivor Perspectives.
Article in Violence against women, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- AI-Enabled First-Response Support After Sexual and Gender-Based Violence: A PRISMA-ScR Scoping Review.Healthcare (Basel, Switzerland) · 2026Review
- From needs assessment to usability testing: evaluating the AinoAid™ chatbot for domestic violence support.BMC women's health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of mobile-based technology to support victim-survivors who are subjected to domestic violence and abuse (DVA) is becoming more prevalent. This article explores the challenges that women who are seeking help for DVA may experience, examining whether a chatbot can offer positive solutions alongside highlighting some of the apprehensions victim-survivors have about its creation and implementation including safety and privacy concerns. We conclude that the chatbot has the potential to be an innovative solution but could also be detrimental for survivors if used as an alternative to investment in preventative, transformative innovations focusing on eliminating DVA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.